BookR: School of Health Core Facilities Booking
PubMed Publications| Keyword search (4,164 papers available) |  |
"Infectious disease" Keyword-tagged Publications:
| Title | Authors | PubMed ID | |
|---|---|---|---|
| 1 | Potential value streams of an integrated Canadian serosurveillance network | Campbell JR; Russell WA; Wagner CE; Manuel DG; Anipindi V; Baral P; Evans TG; Hankins CA; Sander B; | 40588636 CONCORDIA |
| 2 | Candida albicans exhibits heterogeneous and adaptive cytoprotective responses to anti-fungal compounds | Dumeaux V; Massahi S; Bettauer V; Mottola A; Dukovny A; Khurdia SS; Costa ACBP; Omran RP; Simpson S; Xie JL; Whiteway M; Berman J; Hallett MT; | 37888959 BIOLOGY |
| 3 | Impact of biological sex and gender-related factors on public engagement in protective health behaviours during the COVID-19 pandemic: cross-sectional analyses from a global survey | Dev R; Raparelli V; Bacon SL; Lavoie KL; Pilote L; Norris CM; | 35688591 HKAP |
| 4 | The Social Lives of Infectious Diseases: Why Culture Matters to COVID-19 | Bayeh R; Yampolsky MA; Ryder AG; | 34630195 PSYCHOLOGY |
| Title: | Potential value streams of an integrated Canadian serosurveillance network | ||||
| Authors: | Campbell JR, Russell WA, Wagner CE, Manuel DG, Anipindi V, Baral P, Evans TG, Hankins CA, Sander B | ||||
| Link: | https://pubmed.ncbi.nlm.nih.gov/40588636/ | ||||
| DOI: | 10.17269/s41997-025-01075-9 | ||||
| Publication: | Canadian journal of public health = Revue canadienne de sante publique | ||||
| Keywords: | COVID-19; Global health; Infectious disease; Public health; Serology; Surveillance; | ||||
| PMID: | 40588636 | Category: | Date Added: | 2025-07-01 | |
| Dept Affiliation: |
CONCORDIA
1 Respiratory Epidemiology and Clinical Research Unit, Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, QC, Canada. jonathon.campbell@mcgill.ca. 2 Department of Medicine, McGill University, Montreal, QC, Canada. jonathon.campbell@mcgill.ca. 3 Department of Global and Public Health, School of Population and Global Health, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada. jonathon.campbell@mcgill.ca. 4 Department of Epidemiology, Biostatistics, and Occupational Health, School of Population and Global Health, McGill University, Montreal, QC, Canada. 5 Department of Bioengineering, McGill University, Montreal, QC, Canada. 6 Methodological and Implementation Research Program, The Ottawa Hospital Research Institute, Ottawa, ON, Canada. 7 Lunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto, ON, Canada. 8 Department of Global and Public Health, School of Population and Global Health, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada. 9 Office of Vice-President, Research, Innovation and Impact, Concordia University, Montreal, QC, Canada. 10 Health Systems & Policy Research Collaborative Centre, University Health Network, Toronto, ON, Canada. |
||||
Description: |
The Government of Canada, through the COVID-19 Immunity Task Force (CITF), supported over 100 serosurveillance studies during the COVID-19 pandemic, building and strengthening the technical infrastructure necessary for a national serosurveillance network. The value of such a network extends beyond infectious disease surveillance to monitoring non-communicable diseases and chemical and environmental contaminants, advancing immunology and medicine, and contributing to national and international research and training. A serosurveillance network can contribute to skill development and retention of the health workforce and provide a platform to rapidly evaluate diagnostics for emerging pathogens. Although full linkage of health data across jurisdictions remains a challenge for such a serosurveillance network to realize its full potential, there are several value streams that make it a worthwhile goal to pursue: improving population health, supporting policy decisions, and facilitating research and diagnostic development. In the aftermath of the COVID-19 pandemic, an integrated pan-Canadian serosurveillance network is a crucial asset going forward. |
